Stellar Biotechnologies

Stellar Biotechnologies

Stellar Biotechnologies

Stellar Biotechnologies, Inc. (Nasdaq: SBOT) is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH).
Founded
1999
Raised
$6.8M
Follow us
Alexa global traffic share
Latest funding
$6,750,000
Post-IPO debt - 2016
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Stellar Biotechnologies makes some noise.